This combined with the drive to eliminate malaria, is encouraging malaria-endemic countries to increase access to testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.